MedTrace Logo

Effect of Suplementation of Vitamin D in Gestational Diabetes Mellitus

NCT03645109 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-04-02

No results posted yet for this study

Summary

Randomized double-blind placebo-controlled clinical trial. Consists of the administration of 5,000 IU of vitamin D3 vs Placebo in patients with gestational diabetes mellitus during eight weeks. The objective is to analyze the effects of the intervention on the biochemical parameters that are part of the glycemic profile (insuline, HBA1c, glucose)

Conditions

  • Vitamin D3
  • Gestational Diabetes Mellitus in Pregnancy

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Capsules with 5,000 IU of vitamin D3 once a day (one capsule)

OTHER

Capsules with placebo (talcum food grade)

Capsules with placebo (talcum food grade)

Sponsors & Collaborators

  • Eva Elizabet Camarena Pulido

    lead OTHER

Principal Investigators

  • Salvador Mora · OPD Hospital Civil de Guadalajara

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-28
Primary Completion
2020-02-28
Completion
2020-03-10

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03645109 on ClinicalTrials.gov